Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models